The sudden rise of weight loss drugs, or GLP-1s, in the UK is creating uncertainty across the food industry, as analysts assess the likely impact
Already a registered user or member? SIGN IN HERE
To continue reading, register today for free access Register now

Already a registered user or member? SIGN IN HERE